Arsenal, an investment fund specializing in industrial and healthcare businesses, stated that this acquisition will enable ThermoSafe to expand its global operations, meeting the increasing demands of the pharmaceutical and biotechnology industries.
 |
ThermoSafe, under the new ownership of Arsenal Capital Partners, opens opportunities to elevate cold chain technology. Photo: Arsenal Capital Partners |
ThermoSafe, under the new ownership of Arsenal Capital Partners, opens opportunities to elevate cold chain technology. Photo: Arsenal Capital Partners
Headquartered in Arlington Heights, Illinois, US, ThermoSafe is a global provider of temperature-controlled packaging solutions. These solutions ensure the safe and efficient transport of pharmaceuticals, vaccines, biologics, and other healthcare products. The company operates a vertically integrated network, offering shipping solutions for cold, frozen, and controlled room temperatures. Additionally, ThermoSafe's ISC Labs provide design, testing, and validation services that adhere to rigorous industry standards.
George Abd, an operating partner at Arsenal Capital Partners, stated, "ThermoSafe's leading position in the cold chain sector aligns with Arsenal's strategy to partner with and develop businesses, delivering innovation and sustainable value".
He added, "With years of experience and technical capabilities across industrial growth sectors, we look forward to collaborating with Jim Lassiter and the ThermoSafe team to further solidify the company's position as a value-added partner and provider of innovative solutions to the market".
By Nhu Y (According to Fleet Owner)
